Ryan Craig Schoenfeld

USPTO Granted Patents = 25 (Patent Applications = 4)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 12 (Patent Applications = 22)

Average Co-Inventor Count = 3.7

ph-index = 5

Forward Citations = 60(Granted Patents)

Location History:

Nutley, NJ (US) (2012)
San José, CA (US) (2012)
San Jose, CA (US) (2007 - 2013)
Basking Ridge, NJ (US) (2011 - 2016)

Company Filing History:

Hoffmann-la Roche Inc.

patents

Years Active: 2007-2016

Loading Chart...

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9403805 - Antiviral compounds (2016-08-02),

2. 9334278 - Pyrrolo[2,3-B]pyrazines as SYK inhibitors (2016-05-10),

3. 9169215 - LPAR—substituted cyanopyrazole compounds (2015-10-27),

4. 9090559 - Antiviral compounds (2015-07-28),

5. 8658646 - Pyrrolopyrazine kinase inhibitors (2014-02-25),

6. 8513425 - Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives and uses thereof (2013-08-20),

7. 8487103 - Quinoline inhibitors of hepatitis C virus polymerase (2013-07-16),

8. 8329712 - Heterocyclic antiviral compounds (2012-12-11),

9. 8318770 - Tetrahydroquinoline indole derivatives and uses thereof (2012-11-27),

10. 8273773 - Heterocyclic antiviral compounds (2012-09-25),

11. 8198274 - Substituted indolyl and indazolyl derivatives and uses thereof (2012-06-12),

12. 8178547 - Heterocyclic antiviral compounds (2012-05-15),

13. 8158803 - Heterocyclic antiviral compounds (2012-04-17),

14. 8158631 - Heterocyclic antiviral compounds (2012-04-17),

15. 8093285 - Aminopiperidinyl derivatives and uses thereof (2012-01-10),

Title: Innovator Spotlight: Ryan Craig Schoenfeld

Introduction:

Ryan Craig Schoenfeld, a prolific inventor based in San Jose, CA, has made significant contributions to the field of pharmaceuticals with a wealth of patented innovations. With an impressive portfolio of 25 patents, Schoenfeld's work focuses on developing solutions for complex health challenges.

Latest Patents:

1. Antiviral Compounds: Schoenfeld's groundbreaking invention offers compounds, compositions, and methods for treating Hepatitis C Virus (HCV) infection. His pharmaceutical compositions demonstrate promise in combatting HCV infection effectively.

2. Pyrrolo[2,3-B]pyrazines as SYK Inhibitors: Another noteworthy patent by Schoenfeld involves the use of novel pyrrolo[2,3-b]pyrazines as SYK inhibitors. These compounds show potential in the treatment of autoimmune and inflammatory diseases, showcasing his versatility in addressing diverse healthcare needs.

Career Highlights:

Having worked at esteemed companies such as Roche Palo Alto LLC and Hoffmann-La Roche Inc., Schoenfeld has honed his skills and expertise in the pharmaceutical industry. His career highlights underscore his dedication to innovation and his commitment to advancing healthcare technologies.

Collaborations:

Throughout his career, Schoenfeld has collaborated with talented individuals such as Robert James Weikert and Francisco Xavier Talamas. These partnerships have been instrumental in shaping his innovative approach and fostering a culture of shared knowledge within the industry.

Conclusion:

In conclusion, Ryan Craig Schoenfeld's contributions to the field of pharmaceuticals through his patented inventions are a testament to his ingenuity and dedication. His work continues to push the boundaries of healthcare innovation, offering hope for improved treatments in the fight against complex diseases.

This text is generated by artificial intelligence and may not be accurate.